MENU
SMRI
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

SMRI stock forecast, quote, news & analysis

The investment seeks to provide long-term capital appreciation... Show more

Category: #Mid-Cap Value
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for SMRI with price predictions
Nov 17, 2026

SMRI sees MACD Histogram just turned negative

SMRI saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 32 instances where the indicator turned negative. In 25 of the 32 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SMRI moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 15 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 56%.

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SMRI as a result. In 34 of 46 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.

SMRI moved below its 50-day moving average on November 17, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMRI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 25 of 30 cases where SMRI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The 10-day moving average for SMRI crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.

Following a +0.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where SMRI advanced for three days, in 180 of 212 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

SMRI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 211 of 254 cases where SMRI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Micron Technology (NASDAQ:MU), ExxonMobil Holdings Corporation (NYSE:XOM), Netflix Inc. (NASDAQ:NFLX), International Business Machines Corp (NYSE:IBM), Salesforce (NYSE:CRM), ConocoPhillips (NYSE:COP), Accenture PLC (NYSE:ACN), Uber Technologies (NYSE:UBER), Newmont Corp (NYSE:NEM).

Industry description

The investment seeks to provide long-term capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of the fund’s net assets (plus the amount of any borrowings for investment purposes) in U.S. listed common stock.

Market Cap

The average market capitalization across the Bushido Capital US Equity ETF (SMRI) ETF is 95.39B. The market cap for tickers in the group ranges from 9.94B to 1.21T. LLY holds the highest valuation in this group at 1.21T. The lowest valued company is BWA at 9.94B.

High and low price notable news

The average weekly price growth across all stocks in the Bushido Capital US Equity ETF (SMRI) ETF was 4%. For the same ETF, the average monthly price growth was 45%, and the average quarterly price growth was 73%. COP experienced the highest price growth at 4%, while CDE experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Bushido Capital US Equity ETF (SMRI) ETF was 15%. For the same stocks of the ETF, the average monthly volume growth was 5% and the average quarterly volume growth was -16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 72
P/E Growth Rating: 50
Price Growth Rating: 43
SMR Rating: 48
Profit Risk Rating: 54
Seasonality Score: 2 (-100 ... +100)
SMRI sees MACD Histogram just turned negative